CEO and Co-Founder, CoSyne Therapeutics
Dr Louwai Muhammed is the CEO and co-founder of CoSyne Therapeutics – a computational drug target discovery company with a mission to help patients with devastating diseases.
He is a neurology doctor, scientist, and entrepreneur. He read neuroscience and preclinical medicine and Cambridge University, before completing clinical medical school at Oxford University, where he won dozens of academic awards and broke multiple academic records. He then studied entrepreneurship, negotiation and communication at Harvard University as a Kennedy Scholar. While in Boston, he won the Massachusetts institute of Technology (MIT) $100k Accelerate entrepreneurship competition.
He was the top-ranked doctor in the UK for London academic medical training and was the highest scoring applicant to neurology specialist training in the UK. He also founded an internationally recognised teaching platform for medical students in warzones.
Louwai co-founded CoSyne Therapeutics with a team that share his belief that research can be translated faster to help patients more effectively. They are using computational systems genomics to create the next generation of genomic medicines.